当前位置:
X-MOL 学术
›
Nat. Rev. Neurol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Multiple sclerosis: Progressive multifocal leukoencephalopathy risk stratification
Nature Reviews Neurology ( IF 28.2 ) Pub Date : 2017-11-17 , DOI: 10.1038/nrneurol.2017.161 Kalliopi Pitarokoili , Ralf Gold
Nature Reviews Neurology ( IF 28.2 ) Pub Date : 2017-11-17 , DOI: 10.1038/nrneurol.2017.161 Kalliopi Pitarokoili , Ralf Gold
Multiple sclerosis: Progressive multifocal leukoencephalopathy risk stratification , isJats=true)
中文翻译:
多发性硬化症:进行性多灶性白质脑病危险分层
多发性硬化症:进行性多灶性白质脑病危险分层 ,isJats = true)
更新日期:2017-11-17
Multiple sclerosis: Progressive multifocal leukoencephalopathy risk stratification, Published online: 17 November 2017; doi:10.1038/nrneurol.2017.161
NatureArticleSnippet(type=standfirst, markup=A compelling need exists for a more reliable risk evaluation of natalizumab- associated progressive multifocal leukoencephalopathy (PML). A new report proposes a refined protocol that uses updated patient-based data and cumulative risk evaluation to provide an improved assessment of the annual risk of PML for patients positive for JC virus.
中文翻译:
多发性硬化症:进行性多灶性白质脑病危险分层
多发性硬化症:进行性多灶性白质脑病危险分层
多发性硬化症:进行性多灶性白质脑病风险分层,在线发布:2017年11月17日; doi:10.1038 / nrneurol.2017.161
NatureArticleSnippet(type = standfirst,markup =迫切需要对那他珠单抗相关的进行性多灶性白质脑病(PML)进行更可靠的风险评估。一份新的报告提出了一种完善的方案,该方案使用了基于患者的更新数据和累积风险评估,从而为JC病毒阳性患者的PML年度风险提供了更好的评估。